Dermatology Search
Dermatology Dermatology
urticaria
URTICARIA
Urticaria is characterized by sudden appearance of wheals and/or angioedema.
The intensity of the pruritus varies but may be severe enough to disrupt sleep, work or school.
It is classified acute if the urticaria has been present for <6 weeks and chronic if >6 weeks. A specific cause is more likely to be identified in acute cases.
It can be triggered by immunological or nonimmunological mechanism.
Drug Information

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Symptomatic relief of allergic rhinitis eg, sneezing, nasal discharge & itching, as well as ocular itching...

Indication: Prophylaxis & chronic treatment of asthma. Symptomatic relief of day- & nighttime seasonal allergic rh...

Indication: Prophylaxis & chronic treatment of asthma. Symptomatic relief of daytime & nighttime seasonal allergic...

Indication: Rapid relief of symptoms associated w/ allergic rhinitis eg, sneezing, nasal discharge & itching, congesti...

Aerius D-12
desloratadine + pseudoephedrine sulphate

Indication: Symptomatic relief of nasal & non-nasal allergic rhinitis including nasal congestion in adults & child...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold eg, nasal congestion, sneezing, rhinorrhe...

Indication: Symptomatic treatment of perennial & seasonal allergic rhinitis, vasomator rhinitis, allergic conjunctivit...

Indication: Symptomatic treatment of seasonal & perennial allergic rhinitis & urticaria.

1  /  16
1  /  16
Editor's Recommendations
Most Read Articles
Alopecia areata bidirectionally linked to major depressive disorder
21 Apr 2020
A bidirectional association exists between alopecia areata (AA) and major depressive disorder (MDD) among probands and unaffected siblings, reveals a study. This suggests that shared familial mechanisms tend to cause AA and MDD.
Ruxolitinib cream ineffective against alopecia areata
16 Feb 2020
A 1.5% ruxolitinib cream does not seem to be effective for patients with alopecia areata, a recent phase II study has found.